Supplement Own-Labeler’s GMP Stumble Reveals AER Slip
This article was originally published in The Rose Sheet
Executive Summary
FDA warns own-labelers ProSupps USA and Cape Fear Naturals about GMP violations, also pointing out ProSupps dropped the ball on submitting serious AERs to FDA and Cape Fear Naturals made drug claims including “improve blood pressure and cholesterol.”
You may also be interested in...
Market America Asked To Comb Records For Serious AERs About Its Supplements
An FDA inspection found two serious adverse event reports Market America received were not forwarded to the agency as required. Its response didn't answer whether it would review its records "to determine if a serious adverse event report should be submitted to FDA.”
Study Suggests ‘Serious’ Events Are Rare Among All Supplement Adverse Events
Serious adverse events accounted for less than 1% of 41,121 adverse events reported to two supplement firms over 2.5 years, with weight loss agents and products for glycemic management accounting for majority, says a study by regulatory compliance consultants and CRN executives.
GMP Documentation, Identity Testing Continue To Trip Supplement Firms
Warnings from FDA's Office of Regulatory Affairs make clear that failing to document compliance with each GMP requirement renders those parts of the process noncompliant. Warning letters posted March 22 also include FDA's latest enforcement against firms marketing bulk caffeine.